Promethazine Hydrochloride Injection
Product Images NDC 0404-9940

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Promethazine Hydrochloride (NDC 0404-9940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Image1.jpg (Image1)

This text is a warning against using Promethazine hydrochloride injection for pediatric patients below the age of 2 as it may lead to fatal respiratory depression. It also warns that promethazine injection can cause severe chemical irritation and tissue damage regardless of the route of administration. The route of administration is preferably deep intramuscular injection due to the risks of intravenous injection. Subcutaneous injection is contraindicated. Specific details on dosage and administration are available in a separate section.*

FDA Label Image

Image2.jpg (Image2)

This is a label or packaging information for a pharmaceutical product manufactured by a company named "PHARMACEUTICALS" based in Eatontown, NJ, USA. The label has been revised in August 2012 and features a product code of "462-232-05".*

FDA Label Image

Label1.jpg (Label1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.